Why Asia’s biologics boom demands better tools

By Annabelle Kay Last week, I had the privilege of representing Desert Scientific Software in Yokohama at...

READ MORE

The scalability challenge

By Dr Neil Taylor As antibody therapeutics continue their rapid advance, structural biology is producing unprecedented volumes o...

READ MORE

How enriched structural data is reshaping the future of drug discovery

By Dr Neil Taylor

The challenge every pharma company faces

Structure-based drug design (SBDD)...

READ MORE